Real-world safety of first-line (1L) therapies for locally advanced or metastatic urothelial cancer (la/mUC) in the US.

Authors: Amanda Nizam, Mairead Kearney, Valerie A. Morris, Seyed Hamidreza Mahmoudpour, Carroline Lobo, Jason Hoffman, Ilian Iliev, Prakirthi Yerram, Mark Guinter

Published: 2025-02-18

DOI: 10.1200/jco.2025.43.5_suppl.759

Source: Full article

---

Abstract

759